1. E. H. Ho et al., Measuring Information Preferences. Manage Sci (2020). DOI: 10.1287/mnsc.2019.3543.
2. M. C. Bentley et al., Comprehensive chemical characterization of the aerosol generated by a heated tobacco product by untargeted screening. Anal Bioanal Chem 412, 2675-2685 (2020). DOI: 10.1007/s00216-020-02502-1.
3. FDA, PMTA Coversheet: Technical Project Lead Review (TPL) (2019). (Link)
4. Y. Ozaki, et al., Research on actual situation of drinking and smoking and development of effective intervention method of alcohol reduction for prevention of lifestyle-related diseases. A grant research report. (2017). (Link)
5. German Federal Center for Health Education. Smoking in teens and young adults in Germany: Results of the 2018 alcohol survey and trends. (Link)
6. Addiction Suisse. Substance consumption among 11 to 15 year-olds in Switzerland: the situation in 2018 and developments since 1986. Results of the Health Behavior in School-aged Children (HBSC) study (2019). (Link)
7. L. Charrier et al., Smoking habits among Italian adolescents: what has changed in the last decade? Biomed Res Int 2014, 287139 (2014). DOI: 10.1155/2014/287139.
8. D. Bovard et al., A lung/liver-on-a-chip platform for acute and chronic toxicity studies. Lab on a Chip 18, 3814-3829 (2018). (Link)
9. M. B. Fares et al., Assessnebt of potential neuroprotective effects of alkaloids in a human dopaminergic in vitro model of Parkinson's disease. Poster presented at AD/PD conference in 2019. (Link)
10. C. Protano et al., Impact of Electronic Alternatives to Tobacco Cigarettes on Indoor Air Particular Matter Levels. Int J Environ Res Public Health 17, 2947 (2020). DOI: 10.3390/ijerph17082947.
11. W. Slob et al., A Method for Comparing the Impact on Carcinogenicity of Tobacco Products: A Case Study on Heated Tobacco Versus Cigarettes. Risk Analysis 40 (2020). DOI: 10.1111/risa.13482.
12. K. M. Cummings et al., What Is Accounting for the Rapid Decline in Cigarette Sales in Japan? Int J Environ Res Public Health 17 (2020). DOI: 10.3390/ijerph17103570.
13. M. Stoklosa et al., Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tob Control 29, 381-387 (2020). DOI: 10.1136/tobaccocontrol-2019-054998.
14. K. Schimek et al., Human multi-organ chip co-culture of bronchial lung culture and liver spheroids for substance exposure studies. Sci Rep 10, 7865 (2020). DOI: 10.1038/s41598-020-64219-6.
15. D. Bovard et al., A lung/liver-on-a-chip platform for acute and chronic toxicity studies. Lab on a Chip 18, 3814-3829 (2018). DOI: 10.1039/C8LC01029C.
16. G. David et al., Tracing the composition of single e-cigarette aerosol droplets in situ by laser-trapping and Raman scattering. Sci Rep 10, 7929 (2020). DOI: 10.1038/s41598-020-64886-5.
17. P. N. Lee et al., Estimating the population health impact of recently introduced modified risk tobacco products: a comparison of different approaches. Nicotine Tob Res (2020). DOI: 10.1093/ntr/ntaa102.
18. U.S. Food & Drug Administration, Q&A: Modified Risk Tobacco Products (2018). (Link)
19. M. Bosilkovska et al., Exposure to harmful and potentially harmful constituents decreased in smokers switching to Carbon-Heated Tobacco Product. Toxicol Lett 330, 30-40 (2020). DOI: 10.1016/j.toxlet.2020.04.013.